- Product Details
Keywords
- Ibrutinib
- 99.0%~101.0%
- Frontida
Quick Details
- ProName: Ibrutinib
- CasNo: 936563-96-1
- Application: Cancer
- ProductionCapacity: Metric Ton/Day
- Purity: 99.0%~101.0%
- LimitNum: 0 Metric Ton
Superiority
The world's first listed Btk inhibitor can not only effectively inhibit Btk targets, but also effectively act on ITK. Multi target synergy can effectively regulate the differentiation and number of car-t cells. It is the first-line treatment for patients with chronic lymphocytic leukemia (CLL).